Effects of Kampo medicine hangebyakujutsutemmato on persistent postural-perceptual dizziness: A retrospective pilot study

Figure 1 Niigata persistent postural-perceptual dizziness questionnaire score changes after hangebyakujutsutemmato treatment for persistent postural-perceptual dizziness. A: No statistically significant changes in Niigata persistent postural-perceptual dizziness questionnaire (NPQ) scores were seen in the non-hangebyakujutsutemmato (HBT) group (baseline vs 1 mo, P = 0.98; 1 mo vs 2 mo, P = 0.94; baseline vs 2 mo, P = 0.92); B: In the HBT group, NPQ scores showed a statistically significant decrease (baseline vs 1 mo, P = 0.002; 1 mo vs 2 mo, P = 0.003; baseline vs 2 mo, P < 0.001). ^bP < 0.01; ^cP < 0.001. NS: Not significant; NPQ: Niigata PPPD questionnaire; HBT: Hangebyakujutsutemmato; PPPD: Persistent postural-perceptual dizziness.